Publication | Closed Access

Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost

MedicineBrachytherapyClinical TrialsMri-guided BoostSingle-fraction Hdr BrachytherapyMri-guided Radiation TherapyOncologyRadiation OncologyRadiologyHealth Sciences